Australian decision to allow psychedelic drug prescriptions criticised by mental health experts
by Melissa Davey Medical editor from World news | The Guardian on (#6CQKG)
Neuropsychologists and psychiatrists argue the evidence for broad-scale implementation of psychedelic drug use is insufficient
The decision by Australia's drugs regulator to allow authorised psychiatrists to prescribe psychedelic drugs is questionable, if not concerning", and likely driven by the influence of lobby groups instead of health experts, mental health researchers say.
As of 1 July, authorised psychiatrists have been able to prescribe medicines containing psilocybin for treatment-resistant depression, and MDMA for post-traumatic stress disorder. The decision by the Therapeutic Goods Administration followed public consultation, a report from an expert panel and advice received from a medicines advisory committee.
Continue reading...